Discover
LEGN
Legend Biotech Corporation
29.89
2 x 21.60
2 x 37.12
bid
ask
+
1.01
3.50%
2 @ 05:54 AM
30.01 +0.12 (0.40%)
| Ytd | 37.49% | |
| 1y | -16.76% |
28.75
day range
30.24
16.24
52 week range
45.30
| Open | 28.75 | Prev Close | 28.88 | Low | 28.75 | High | 30.24 | Mkt Cap | 5.78B |
| Vol | 1.62M | Avg Vol | 2.75M | EPS | -1.38 | P/E | N/A | Forward P/E | 21.63 |
| Beta | 0.35 | Short Ratio | 4.78 | Inst. Own | 53.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 28.97 | 200-d Avg | 25.51 | 1yr Est | 57.43 |
| Income Statement | |||
| Total Revenue | 305.10M | ||
| Revenues (USD) | 305.10M | ||
| Cost of Revenue | 175.90M | ||
| Gross Profit | 129.20M | ||
| Operating Expenses | 179.00M | ||
| Research and Development Expense | 85.70M | ||
| Selling, General and Administrative Expense | 90.10M | ||
| Operating Income | -49.80M | ||
| Interest Expense | 5.50M | ||
| Income Tax Expense | 1.20M | ||
| Net Income | -54.30M | ||
| Net Income Common Stock | -54.30M | ||
| Net Income Common Stock (USD) | -54.30M | ||
| Consolidated Income | -54.30M | ||
| Earnings per Basic Share | -0.30 | ||
| Earnings per Basic Share (USD) | -0.30 | ||
| Earnings per Diluted Share | -0.30 | ||
| Earning Before Interest & Taxes (EBIT) | -47.60M | ||
| Earning Before Interest & Taxes (USD) | -47.60M | ||
| Weighted Average Shares | 369.89M | ||
| Balance Sheet | |||
| Cash and Equivalents | 834.60M | ||
| Cash and Equivalents (USD) | 834.60M | ||
| Trade and Non-Trade Receivables | 1.70M | ||
| Current Assets | 1.08B | ||
| Property, Plant & Equipment Net | 452.50M | ||
| Total Assets | 1.60B | ||
| Debt Current | 277.20M | ||
| Total Debt | 389.30M | ||
| Current Liabilities | 509.10M | ||
| Debt Non-Current | 112.10M | ||
| Total Liabilities | 629.00M | ||
| Shareholders Equity | 967.70M | ||
| Shareholders Equity (USD) | 967.70M | ||
| Assets Non-Current | 514.00M | ||
| Total Debt (USD) | 389.30M | ||
| Deferred Revenue | 6.00M | ||
| Inventory | 37.10M | ||
| Liabilities Non-Current | 119.90M | ||
| Trade and Non-Trade Payables | 204.50M | ||
| Tax Liabilities | 20.30M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 15.60M | ||
| Net Cash Flow from Financing | -1.20M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -255.50M | ||
| Capital Expenditure | -7.50M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -18.40M | ||
| Issuance (Purchase) of Equity Shares | 100.00K | ||
| Issuance (Repayment) of Debt Securities | -1.30M | ||
| Net Cash Flow from Investing | -168.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -142.10M | ||
| Net Cash Flow from Operations | -85.10M | ||
| Effect of Exchange Rate Changes on Cash | -1.20M | ||
| Share Based Compensation | 19.30M | ||